Literature DB >> 17680719

Mechanism of internalization of an ICAM-1-derived peptide by human leukemic cell line HL-60: influence of physicochemical properties on targeted drug delivery.

Sumit Majumdar1, Naoki Kobayashi, Jeffrey P Krise, Teruna J Siahaan.   

Abstract

Peptide-mediated targeted delivery offers an attractive strategy for selective delivery of cytotoxic drugs to cancer cells. In this work, we have investigated the mechanism of internalization of cIBR peptide [cyclo(1,12)PenPRGGSVLVTGC] that is conjugated with fluorescein isothiocyanate (FITC) and doxorubicin (DOX) to give FITC-cIBR and DOX-cIBR conjugates, respectively. Internalization mechanisms of FITC-cIBR and DOX-cIBR were studied in LFA-1-expressing cells (HL-60) and LFA-1-deficient cells (HUVEC) under the following conditions: (a) at two different temperatures (4 and 37 degrees C), (b) in the presence of ATP-depleting agents (sodium azide and 2-deoxy- d-glucose), and (c) in the presence of a microtubule-disrupting agent (nocodazole). At 37 degrees C, FITC-cIBR was internalized by HL-60 cells and located in the endosomes; however, it was not internalized by LFA-1-deficient HUVEC. Incubation of FITC-cIBR at 4 degrees C or in the presence of nocodazole inhibited its endocytosis in HL-60 cells. The ATP inhibitors inhibited the internalization of FITC-cIBR but maintained its binding to cell surface receptors. In contrast, DOX-cIBR was diffusely distributed in the cytoplasm of LFA-1-expressing HL-60 cells following incubation at 37 degrees C. No inhibitory processes could block the entry or change the distribution pattern of DOX-cIBR into HL-60 cells, suggesting that DOX-cIBR uptake was not mediated by receptors such as LFA-1. DOX-cIBR was still found inside HUVEC, but with a distribution pattern somewhat different from that in HL-60 cells. The major entry mechanism of DOX-cIBR could be via passive diffusion because DOX-cIBR has an octanol/water distribution coefficient (Log D) of 1.15. Thus, DOX-cIBR is more lipophilic than FITC-cIBR with a Log D of 0.57. Therefore, the change in the hydrophobicity of the conjugate may alter the mechanism of entry of DOX-cIBR compared to that of FITC-cIBR. This study suggests that alteration of the physicochemical properties of drug-peptide conjugates can change the mode of uptake from receptor-mediated uptake to passive diffusion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17680719     DOI: 10.1021/mp0700458

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

1.  Methotrexate (MTX)-cIBR conjugate for targeting MTX to leukocytes: conjugate stability and in vivo efficacy in suppressing rheumatoid arthritis.

Authors:  Sumit Majumdar; Meagan E Anderson; Christine R Xu; Tatyana V Yakovleva; Leo C Gu; Thomas R Malefyt; Teruna J Siahaan
Journal:  J Pharm Sci       Date:  2012-04-26       Impact factor: 3.534

2.  cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.

Authors:  Chuda Chittasupho; Prakash Manikwar; Jeffrey P Krise; Teruna J Siahaan; Cory Berkland
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

3.  Rapid identification of fluorochrome modification sites in proteins by LC ESI-Q-TOF mass spectrometry.

Authors:  Prakash Manikwar; Tahl Zimmerman; Francisco J Blanco; Todd D Williams; Teruna J Siahaan
Journal:  Bioconjug Chem       Date:  2011-06-07       Impact factor: 4.774

Review 4.  Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases.

Authors:  Mario E G Moral; Teruna J Siahaan
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

5.  Effect of modification of the physicochemical properties of ICAM-1-derived peptides on internalization and intracellular distribution in the human leukemic cell line HL-60.

Authors:  Sumit Majumdar; Bimo A Tejo; Ahmed H Badawi; David Moore; Jeffrey P Krise; Teruna J Siahaan
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

6.  Catechin-mediated restructuring of a bacterial toxin inhibits activity.

Authors:  En Hyung Chang; Joanne Huang; Zixiang Lin; Angela C Brown
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-10-17       Impact factor: 3.770

7.  Solution structure of a novel T-cell adhesion inhibitor derived from the fragment of ICAM-1 receptor: cyclo(1,8)-Cys-Pro-Arg-Gly-Gly-Ser-Val-Cys.

Authors:  Bimo A Tejo; Teruna J Siahaan
Journal:  Biopolymers       Date:  2009-08       Impact factor: 2.505

8.  Advancement and applications of peptide phage display technology in biomedical science.

Authors:  Chien-Hsun Wu; I-Ju Liu; Ruei-Min Lu; Han-Chung Wu
Journal:  J Biomed Sci       Date:  2016-01-19       Impact factor: 8.410

9.  Improving Brain Delivery of Biomolecules via BBB Modulation in Mouse and Rat: Detection using MRI, NIRF, and Mass Spectrometry.

Authors:  Kavisha R Ulapane; Ngoc On; Paul Kiptoo; Todd D Williams; Donald W Miller; Teruna J Siahaan
Journal:  Nanotheranostics       Date:  2017-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.